Trials / Recruiting
RecruitingNCT06643507
Evaluation of the Modified VISTA Technique Using ALB-PRF vs CTG in the Treatment of Multiple Miller Class III Recessions
Clinical Evaluation of the Modified VISTA Technique (M-VISTA )Using Albumin-platelet Rich Fibrin (Alb-PRF) Versus Connective Tissue Graft (CTG)in the Treatment of Multiple Miler Class III RT2 Recessions A Randomized Clinical Trial
- Status
- Recruiting
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 26 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
treatment of miller class III RT2 gingival recession using modified vista technique using connective tissue graft vs albumin PRF
Detailed description
treatment of gingival recession is an important element in the treatment of periodontitis this study covers clinical evaluation of using the modified VISTA technique with using Albumin-PRF VS connective tissue graft in the treatment of miller class III / RT2 for root coverage outcomes
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Connective tissue graft | regenerative properties |
| BIOLOGICAL | ALB-PRF | regenerative properties |
Timeline
- Start date
- 2025-04-20
- Primary completion
- 2026-12-20
- Completion
- 2027-01-30
- First posted
- 2024-10-16
- Last updated
- 2026-03-20
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06643507. Inclusion in this directory is not an endorsement.